# Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma

> **NCT02109146** · PHASE3 · COMPLETED · sponsor: **Zhejiang University** · enrollment: 332 (actual)

## Conditions studied

- Hepatocellular Carcinoma
- Transcatheter Arterial Chemoembolization

## Interventions

- **DRUG:** Prophylactic Transcatheter Arterial Chemoembolization
- **OTHER:** Observation

## Key facts

- **NCT ID:** NCT02109146
- **Lead sponsor:** Zhejiang University
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-03-26
- **Primary completion:** 2023-05-13
- **Final completion:** 2023-05-13
- **Target enrollment:** 332 (ACTUAL)
- **Last updated:** 2024-05-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02109146

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02109146, "Postoperative TACE(Transhepatic Arterial Chemotherapy And Embolization) for Patients With Hepatocellular Carcinoma". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02109146. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*